Archive - February 2006

• First Australian population-based estimates of HF prevalence (28/02/2006)
• Drug eluting stents offer similar benefits: REALITY (28/02/2006)
• Australian study clarifies effects of haemochromatosis genes (28/02/2006)
• Facilitated PCI no advantage over primary PCI (27/02/2006)
• Over 50% of Australians not eating enough fruit and veg (27/02/2006)
• CVD costs Europe billions (24/02/2006)
• Patient vigilance can help detect drug-related hepatotoxicity (24/02/2006)
• RIO study reports cardiometabolic and weight results with rimonabant (23/02/2006)
• The impact and management of stroke in Australia: AIHW report (23/02/2006)
• 'Silent' MI common in the over-55s (21/02/2006)
• The cardiovascular manifestations of rheumatic diseases (21/02/2006)
• FDA issues public-health advisory on aprotinin (21/02/2006)
• Ximelagatran pulled from worldwide market (21/02/2006)
• Metabolic syndrome: one single factor or many? (20/02/2006)
• Australian margarines now have negligible levels of trans fat (20/02/2006)
• Warfarin for AF linked to osteoporotic fractures (20/02/2006)
• Bulk-billing up 8.6% after Government incentives (20/02/2006)
• Socioeconomic status and stroke: more research required (17/02/2006)
• Statin role in diabetes continues to evolve (17/02/2006)
• HealthConnect deadline pushed out again (17/02/2006)
• Caution needed on applying prediction rules in clinical practice (16/02/2006)
• Repetition the go for heart sound recognition - MO News (16/02/2006)
• Absence of established risk factors at 50 years of age associated with low lifetime risk for CVD (14/02/2006)
• Didgeridoo playing improves sleep apnoea (14/02/2006)
• Puppy power for critically ill - MO News (14/02/2006)
Displaying results 1-25 (of 47)
 |<  < 1 - 2  >  >| 

Back to archive ...